ENANTA PHARMACEUTICALS INC (ENTA)
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2026
OLEMA PHARMACEUTICALS, INC. (OLMA)
Olema Oncology Reports Second Quarter 2026 Financial and Operating Results
PLUG POWER INC (PLUG)
Plug Reports Revenue of ~$178 Million, ~Break-Even Gross Margin, Net Cash Usage of ~$61 Million and Increases Revenue Guidance for 2026
GALAPAGOS NV (LKFT)
Lakefront Biotherapeutics Reports Half-Year 2026 Financial Results and Provides Business Update
BRIDGEBIO PHARMA, INC. (BBIO)
BridgeBio Reports Second Quarter 2026 Financial Results and Corporate Updates
GALAPAGOS NV (LKFT)
Lakefront Biotherapeutics rapporteert halfjaarcijfers 2026 en geeft een update over de activiteiten
ROCKET PHARMACEUTICALS, INC. (RCKT)
Rocket Pharmaceuticals Reports Second Quarter 2026 Financial Results and Highlights Recent Progress
ALTI GLOBAL, INC. (ALTI)
AlTi Global, Inc. Reports Second Quarter 2026 Financial Results
OPERA LTD (OPRA)
Opera to Report Q2 2026 Financial Results Ahead of Schedule on August 19, 2026
FIRST HORIZON CORP (FHN)
James Petrillo Joins First Horizon Bank as Vice President, De Novo New Build Leader